Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Miura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Miura, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 19, 14139-14146, May 12, 2000


Hypoxic Induction of Prolyl 4-Hydroxylase alpha (I) in Cultured Cells*

Yuji TakahashiDagger §, Shigeru TakahashiDagger , Yuko Shiga, Tatsuya Yoshimi, and Takashi Miura

From the Laboratory of Environmental Molecular Physiology, School of Life Science, Tokyo University of Pharmacy and Life Science, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Accumulated evidence indicates that hypoxia activates collagen synthesis in tissues. To explore the molecular mechanism of activation, we screened genes that are up-regulated or down-regulated by hypoxia. Fibroblasts isolated from fetal rat lung were cultured under hypoxia. Differential display technique showed that the mRNA level of prolyl 4-hydroxylase (PH) alpha (I), an active subunit that catalyzes the oxygen-dependent hydroxylation of proline residue in procollagen, increased 2-3-fold after an 8-h exposure to hypoxia. This elevated level was maintained over 40 h and returned to the basal level after reoxygenation. The transcription rate, protein level, and hydroxyproline content (an indicator of the prolyl hydroxylation) were all elevated by hypoxic culture. Analysis of the promotor region of PHalpha (I) gene indicated that a motif similar to hypoxia-responsive element (HRE) of hypoxia-inducible genes such as erythropoietin, was identified within a 120-base pair sequence upstream of the transcription start site. Luciferase reporter assay and mutational analysis showed that a site similar to the HRE in this motif is functionally essential to hypoxic response. Electrophoretic mobility shift assay revealed that hypoxia-inducible factor-1 was stimulated and bound to the PHalpha (I) HRE upon hypoxic challenge. Our results indicate that PHalpha (I), an essential enzyme for collagen synthesis, is a target gene for hypoxia-inducible factor-1.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Restricted oxygen availability is a feature of many physiologic and pathologic conditions, including high altitude residence, fetal development in the uterus, pulmonary fibrosis, wounded tissue, and neoplasm (1). Systemic and cellular responses to reduced oxygen tension (hypoxia) are initiated by activation and/or inactivation of gene expression. Hypoxia-inducible factor-1 (HIF-1),1 which was originally found to be a critical mediator for the inducible expression of the erythropoietin (Epo) gene by hypoxia (2), is a heterodimer composed of HIF-1alpha and arylhydrocarbon receptor nuclear translocator (ARNT). HIF-1alpha and ARNT retain a basic helix-loop-helix domain and a Per-ARNT/aryl hydrocarbon receptor Sim domain in their N termini (2). Hypoxia induces stabilization of HIF-1alpha (3), heterodimerization of HIF-1alpha and ARNT (4), and the binding of the heterodimer to the hypoxia-responsive element (HRE) in the regulatory region of the target genes with the transcriptional coactivator p300/CREB-binding protein (5). Although posttranscriptional mechanisms may contribute to the induction of hypoxia-sensitive genes, activation of the HIF-1 complex is an important step leading to hypoxia-mediated induction of glycolytic enzymes (6-9), Epo (2), vascular endothelial growth factor (10), and tyrosine hydroxylase (11).

In the remodeling of the small muscular pulmonary artery observed in hypoxia-induced pulmonary hypertension, type I collagen is actively synthesized and accumulated in the media and the adventitia of the artery (12). Recent studies have revealed that in vivo exposure of rats to hypoxia increases prolyl hydroxylase activity in skeletal muscle (13) and increases the concentration of collagenous proteins in cardiac muscle (14). Moreover, in vitro exposure of rat mesangial cells (15) and dermal fibroblasts (16) to hypoxia results in the enhancement of type IV collagen protein level and type I procollagen mRNA level, respectively. These observations indicate that systemic and cellular hypoxia modulates collagen synthesis in several types of cells. Synthesis of collagen molecules can be regulated at several steps (17). After translation, procollagens are hydroxylated on proline residues at the endoplasmic reticulum and form stable triple-helical trimers. The secreted procollagen trimer is proteolytically cleaved at both N-and C-propeptides in the extracellular space, where collagen trimers polymerize and are deposited nonenzymatically. These sequential steps of collagen synthesis and hypoxic effects on several stages in the expression of multiple types of collagen genes imply that hypoxic regulatory factors may be involved in common reactions during the collagen synthesis process.

To explore the molecular mechanism, we screened hypoxia-responsive genes in isolated fetal rat lung fibroblasts using the differential display method. We subsequently found that prolyl 4-hydroxylase (PH) alpha (I), an active subunit that catalyzes oxygen-dependent hydroxylation of proline residue in procollagen, is up-regulated by hypoxia via HIF-1 transcription factor complex.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Culture-- Fibroblasts were isolated from the fetal rat lung at 19 days of gestation (18). IMR-90 and WI-38, human fetal lung fibroblast cell lines, were obtained from the RIKEN Cell Bank (Tokyo, Japan). These cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), 100 units/ml penicillin, 100 µg/ml streptomycin, 1 mM sodium pyruvate, 0.1 mM minimum essential medium nonessential amino acid, 1× minimum essential medium vitamin, and 15 mM HEPES (pH 7.4). Fetal rat lung fibroblasts between the 20th and 25th passages were used for the experiments. The mouse hepatoma cell lines Hepa-1c1c7 (Hepa-1) and its ARNT-defective derivative, Hepa-c4, were generously supplied by O. Hankinson. Hepa-c4 cells lack ARNT function and also fail to express the ARNT protein (19). These cells were cultured in the minimal essential medium-alpha without nucleosides (Life Technologies, Inc.) supplemented with 10% FCS, 100 units/ml penicillin, 100 µg/ml streptomycin, 2 mM glutamine, and 15 mM HEPES (pH 7.4). At subconfluence, cells were exposed to hypoxia or treated with chemicals. Exposures of cells to hypoxia were performed as described previously (9). In some experiments, 200 µM ascorbic acid was added to the medium.

Differential Display and Transcriptional Run-on Assay-- We followed the fluorescent differential display method developed by Ito et al. (20) with several modifications, as described in a previous paper (9). Transcriptional run-on assay was performed as described previously (9). The amount of PHalpha (I) transcript was standardized by comparison with the beta -actin signal.

RNA Blotting-- Probes for RNA blot analysis were prepared by reverse transcription-polymerase chain reaction with rat total RNA extracted from the lung as mentioned previously (21). The following sense and antisense primers were used: rat PHalpha (I), DDBJ/EMBL/GenBankTM accession no. X78949, nucleotides 103-122, and nucleotides 1085-1066. RNA blotting was performed as described previously (22). After analysis of the PHalpha (I) mRNA level, the probe was stripped with a low salt wash at 90 °C. The membrane was reprobed for 28 S rRNA. The intensity of the mRNA was normalized to the 28 S rRNA signal (23).

Preparation of Cell Homogenate-- The fibroblast monolayer was washed three times with phosphate-buffered saline (PBS), then scraped and pelleted by centrifugation at 100 × g for 5 min at 4 °C. Cell pellets were washed once with PBS. The cell pellets were suspended in a 10× volume of 0.2 M NaCl, 0.1 M glycine, 20 mM Tris-HCl (pH 7.5 at 4 °C) containing 0.1% Triton X-100, 0.2 mM phenylmethylsulfonyl fluoride, 0.5 mM dithiothreitol and kept on ice for 10 min, followed by homogenization in a Potter-Elvehjem homogenizer at 1200 rpm with 10 up-and-down strokes. The homogenate was analyzed for PHalpha by protein blotting.

Protein Blotting-- Protein blotting was performed as mentioned previously (9) with some modifications. For PHalpha detection, equivalent amounts of protein from each sample were subjected to 10% SDS-polyacrylamide gel electrophoresis and then electrically transferred overnight at 25 °C from the gel to nitrocellulose membranes. The blots were incubated with mouse anti-rat PHalpha monoclonal antibody (Fuji Chemical, Toyama, Japan) at 0.3 µg IgG per ml of 0.1% Tween 20-Tris-buffered saline (TTBS) for 1 h at 25 °C, and then rinsed three times in TTBS for 15 min. The blotted membranes were probed with horseradish peroxidase-conjugated goat anti-mouse IgG at a dilution of 1:3000 for 1 h. After four washes with TTBS, antibody-antigen complexes were detected using an enhanced chemiluminescence detection kit (Amersham Pharmacia Biotech) according to the manufacturer's protocol.

Quantification of Hydroxy Proline, DNA, and Protein-- To analyze hydroxy proline in the culture medium, fibroblasts at subconfluency were cultured in 10% FCS-DMEM with or without 200 µM ascorbic acid under either 20 or 0% O2 for 24 h. For the next 24 h, cells were maintained in 0.1% FCS-DMEM with or without 200 µM ascorbic acid under either 20 or 0% O2. The culture medium was collected and hydrolyzed in 6 N HCl for 16 h at 116 °C. To analyze the hydroxy proline in the cells and cell-associated matrix, subconfluent fibroblasts were cultured for 8 days. The culture medium was changed every other day. After three washes with PBS, the cell layer was harvested by scraping and hydrolyzed. The 4-hydroxy proline in the hydrolyzate was determined by the colorimetric method (24, 25). The DNA content of the cell homogenate was assayed by the fluorochrometric method using DNA-binding fluorochrome Hoechst 33258 (26). The protein content was measured by the colorimetric method using the Pierce BCA protein assay kit, according to the manufacturer's manual. BSA was used as the standard.

Transient Transfections and Reporter Gene Assays-- The rat genomic library was screened against rat PHalpha (I) cDNA probe containing a 5'-untranslated region. One clone covering from 1.9 kb 5'-upstream of the transcription starting site to the first exon was selected to analyze responses of PHalpha (I) gene to hypoxia.2 A region from -1.9 kb to +68 bases (transcription start site was transiently determined by the 5'-RACE method, Clontech, Palo Alto, CA) was ligated to Photinus pyralis luciferase reporter vector (pGL3-basic, Promega, Madison, WI) and designated prPHLUC19. Deletion mutants of prPHLUC19 containing regions from -117 to +68 and from -68 to +68, were constructed and designated prPHLUC(-117) and prPHLUC(-68), respectively. Mutation of the putative HRE sequence 5'-CGCACGTA-3' (27) at position -86 to -79 in the sense DNA strand of the prPHLUC(-117) plasmid by replacement of the bases ACG with TTT to construct prPHLUC(-117)m was introduced by using the QuikChangeTM site-directed mutagenesis kit (Stratagene, La Jolla, CA). All constructs were verified by DNA sequencing. Subconfluent cultures of rat lung fibroblasts, Hepa-1 cells, and Hepa-c4 cells were cultured in 60-mm dishes. When the cultures reached subconfluence, cells were transfected by PHalpha (I)-luciferase chimeric plasmids, the promotor-less luciferase plasmid (a negative control vector, pGL3-basic, Promega, Madison, WI) or the SV40-promoter/enhancer containing luciferase plasmid (a positive control vector, pGL3-control) concomitantly with 0.1 µg of pRL-SV40, an internal control plasmid containing Renilla reniformis luciferase gene. Test plasmid (0.45 pmol), 5 µl of FuGENE6 trasfection reagent (Roche Molecular Biochemicals), and 95 µl of serum-free medium complex were added to the cultured cells. After 24 h incubation, cells were exposed to hypoxic gas for 16 h, and then lysed. Cell lysates were used to determine luciferase activity using Lumat LB 9501 (EG & G Berthold, Bad Wildbad, Germany).

Preparation of Whole Cell Extracts and Electrophoretic Mobility Shift Assay-- The cell monolayer was washed once with PBS and then scraped. After centrifugation at 100 × g for 5 min at 4 °C, cell pellets were washed once with PBS, quickly frozen in liquid nitrogen for more than 5 min, and thawed on ice for 5-10 min with a 5-fold cell-packed volume of cell lysis buffer (50 mM HEPES-KOH, pH 7.9, 420 mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM dithiothreitol, 1 mM sodium orthovanadate, 1× CompleteTM (protease inhibitor mixture, Roche Molecular Biochemicals), 20% glycerol). Cells were lysed at 4 °C by multiple (20) passages through a 26 gauge needle, followed by centrifugation at 12000 × g for 15 min at 4 °C. The supernatants were frozen in liquid nitrogen and stored at -85 °C until use. Mouse Epo 3'-enhancer oligonucleotide (5'-GCC CTA CGT GCT GCC TCG CAT GGC-3') (27), PHalpha (I) 5'-enhancer oligonucleotide (from -91 to -74, numbered with the transcription start site as +1; 5'-CTG AGC GCA CGT AGC GAG-3'), and PHalpha (I)-M oligonucleotide (5'-CTG AGC GCT TTT AGC GAG-3') were used as probes or competitors. Both strands of oligonucleotide probes were labeled with [gamma -32P]ATP (111 TBq/mmol) and T4 polynucleotide kinase and then annealed in 20 mM Tris-HCl, pH 7.5, 10 mM MgCl2, and 50 mM NaCl by heating at 80 °C for 5 min followed by gradual cooling to 25 °C over 60 min. The annealed probes were purified by passing them through an NAP-column (Amersham Pharmacia Biotech). A typical DNA binding reaction was carried out by mixing 15 µg of cell extract with 20 µl of DNA binding buffer (10 mM Tris-HCl, pH 7.5, 50 mM KCl, 1 mM MgCl2, 0.5 mM EDTA, 5 mM dithiothreitol, 280 ng of sonicated poly(dI-dC), 1× CompleteTM) for 5 min at 25 °C. Probes (20 fmol) and competitors (2 pmol) were added and incubated for a further 10 min at 25 °C. Reaction products were electrophoresed at 4 °C on 5% polyacrylamide in 30 mM Tris/30 mM boric acid, 0.3 mM EDTA (pH 7.3 at 20 °C). For supershift assay, 1 µg of monoclonal anti-HIF-1alpha antibody (H1alpha 67, Novus Biochemical, Littleton, CO) or anti-Flag-epitope tag antibody as control (M5, Sigma), were incubated with 15 µg of whole cell extract at 4 °C for 90 min.

Statistics-- Analyses of significant differences between data sets were performed by the use of Student's t test or Welch's t test after analysis of variance. Values of p < 0.05 were considered statistically significant.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Differential Display-- Gene products up-regulated or down-regulated by a 16-h exposure of fetal rat lung fibroblasts to 0% O2 were screened by the differential display technique using 104 combinations of arbitrary primers and anchor primers. Polymerase chain reaction with arbitrary primer 5'-TTTTGGCTCC-3' and fluorescein isothiocyanate-labeled anchor primer 5'-GT15VA amplified a fragment at base pair 350, where the intensity from hypoxic cells is higher than that from normoxic cells (Fig. 1, left). This difference was confirmed by amplification with the same pair of primers using [35S]dCTP (Fig. 1, right). Cloning of this band combined with a computer search of sequence similarity revealed that this amplified DNA was the 3'-fragment of PHalpha (I) cDNA.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   Differential display. Subconfluent cultures of fetal rat lung fibroblasts were either maintained under 20% O2 (N) or exposed to 0% O2 (H) for 16 h. Complemental DNA was reverse-transcribed from the total RNA extracted from the cells. Products of polymerase chain reaction amplification with arbitrary primer 5' TTTTGGCTCC-3' and fluorescein isothiocyanate-labeled anchor primer 5'-GT15VA (V is a mixture of A, C, and G) were separated on a DNA sequencer, and the fragment pattern was analyzed by fragment manager software (left panel). A peak (left panel, arrow), showing different abundances between 20% O2 culture and 0% O2 culture, was confirmed by polymerase chain reaction amplification with 35S-labeled nucleotide and autoradiography of the fragment separated on sequence gel (right panel). The corresponding band, indicated by the arrow, was subjected to cloning and sequencing. Positions of simultaneously run molecular mass markers are shown on both sides.

Kinetics of Increases in PHalpha (I) mRNA Levels after Hypoxia-- To examine the response of PHalpha (I) gene expression to low oxygen culture, the steady state level of PHalpha (I) mRNA was determined by RNA blot analysis. Fibroblasts at subconfluency were cultured for 16 h at various concentrations of O2 from 20 to 0%. The PHalpha (I) mRNA level increased in a hypoxic stress-dependent manner (Fig. 2A). The PHalpha (I) mRNA signal, normalized to 28 S rRNA, increased to 1.3-fold the control after 3% O2 culture. This response was enhanced by hypoxic conditions of 2 to 0% O2. Increases in the PHalpha (I) mRNA level after hypoxia reached their peak at 0% O2, a value 3.0-fold that of the 20% O2 control. Time dependence was determined in the cells cultured under 0% O2 (Fig. 2B). An increase in the PHalpha (I) mRNA level became evident after 8 h hypoxia and reached its maximum after 16 h. This increased level was maintained for 40 h of hypoxic exposure. After fibroblasts were returned from 16 h of hypoxic culture to normoxic atmosphere (reoxygenation), the elevated level of PHalpha (I) mRNA decreased slightly after 4 h reoxygenation and returned to the prehypoxic value after 24 h of reoxygenation.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 2.   Kinetics of the PHalpha (I) mRNA level after hypoxia. A, after fetal rat lung fibroblasts reached subconfluence under normoxia, cells were maintained at 20% O2 (inset, lane 1) or exposed to hypoxia (5-0% O2; inset, lanes 2-7) for 16 h. Following extraction of total RNA, the steady state level of PHalpha (I) mRNA was determined by the RNA blotting method (inset, top). Radioactivity was estimated as mentioned under "Experimental Procedures" and normalized to the 28 S rRNA signal (inset, bottom) and then expressed as a level relative to the control. B, subconfluent fibroblasts were either maintained at 20% O2 or exposed to 0% O2 for various lengths of time, as indicated. In certain experiments, after 16 h in 0% O2, fibroblasts were returned to 20% O2 for the indicated times (reoxygenation). The steady state level of PHalpha (I) mRNA was analyzed and expressed as in A.

IMR-90 and WI-38, human fetal lung fibroblast cell lines, also showed increases in the PHalpha (I) mRNA level by 2.5-3.0-fold the normoxic control in response to 16 h of hypoxic exposure (data not shown).

Run-on Transcription Analysis-- The increase of PHalpha (I) mRNA levels by hypoxic cultures pointed to a transcriptional effect on PHalpha (I) expression. To assess this aspect, we measured PHalpha (I) gene transcription in isolated nuclei. The transcriptional rate of PHalpha (I), normalized to the beta -actin signal, significantly increased to 2.2-fold (p < 0.05) and 3.3-fold (p < 0.05) of the normoxic control after 4 and 8 h of exposure to 0% O2, respectively (Fig. 3). Transcription of beta -actin appeared to be unchanged under the same conditions. LDH-A, a positive control gene (6), showed 1.4- and 1.8-fold (p < 0.05) increases in the relative transcription rate after 4 and 8 h of 0% O2 exposure, respectively. Vector DNA did not show any signal.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 3.   Transcriptional rate of PHalpha (I) mRNA. Nylon membranes binding plasmid DNA of PHalpha (I), LDH-A, and beta -actin (top) were hybridized with 32P-labeled run-on transcripts from 1 × 107 nuclei isolated from fibroblasts cultured under normoxia or hypoxia for 4 or 8 h. As the control DNA, pBluescript KS bound to nylon membrane was hybridized with nascent 32P-labeled RNA as above. Radioactivities of newly transcribed PHalpha (I) and LDH-A levels were normalized to beta -actin and expressed as increases relative to control levels (bottom). Means and standard errors from three experiments are shown. Statistically significant differences between normoxia and hypoxia are shown (*, p < 0.05).

Levels of PHalpha Protein and Hydroxyproline Residue-- To determine the protein level of PHalpha in fibroblasts, we probed the whole cell homogenate by protein blotting for the presence of PHalpha protein. Anti-rat PHalpha monoclonal antibody detected a band at 63,000 daltons in the fibroblasts, which co-migrated with authentic PHalpha (I) (Fig. 4A). After 4 h of exposure to 0% O2, the protein level of PHalpha significantly increased to 1.3-fold (p < 0.05) the control level (Fig. 4B). The protein level reached its peak after 24 h of 0% O2 exposure, which was 1.9-fold (p < 0.05) the control. The elevated level was maintained after 32 h exposure to hypoxia. This protein response to hypoxic culture was similar to that observed for mRNA levels.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4.   Protein level of PHalpha . Subconfluent fibroblasts were either maintained in 20% O2 or exposed to 0% O2 for 4-32 h. The PHalpha protein levels were determined by the protein blotting method using anti-PHalpha antibody as described under "Experimental Procedures." Lane S represents authentic PHalpha protein, and lanes 1-6 represent samples harvested from 20% O2 and from 0% O2 for 4, 8, 16, 24, and 32 h, respectively (A). On the right, migration of the simultaneously run molecular mass marker is shown (arrowheads from the top down represent origin and 97.4, 66, 45, 31, and 21.5 kDa, respectively). Densitometric analysis was performed, and intensity relative to 20% O2 control was expressed. Means and standard errors from three experiments are shown (B). Differences between the control (0 h) and each hypoxic sample (4, 8, 16, 24, and 32 h) were statistically significant (*, p < 0.05).

Hydroxylation of proline residue in procollagen occurs in the endoplasmic reticulum and is important for stabilizing the procollagen trimer. Hydroxylated procollagen is assembled for secretion from the cell to the culture medium, in which the C- and N-propeptides of procollagen are cleaved enzymatically, resulting in deposition of collagen polymers on the cell surface. To assess the in vivo hydroxylation activity, fibroblasts were cultured under either normoxia or hypoxia in the presence or absence of ascorbic acid. We determined the levels of hydroxy- proline residue secreted from fibroblasts into the medium over 24 h. With the addition of ascorbic acid, hypoxic culture had no significant effect on the hydroxyproline content of the conditioned medium (Fig. 5A). Under normoxic culture, ascorbic acid depletion decreased the hydroxyproline content of the medium to 7% of the ascorbic acid-sufficient culture. Interestingly, without ascorbic acid, hypoxic culture restored the hydroxyproline level from 7 to 58% of ascorbic acid-supplemented and normoxic cultures. We analyzed the hydroxyproline residue that had accumulated in the cell or cell-associated matrix during the 8-day confluent culture period. Ascorbic acid and hypoxic culture affected the hydroxyproline level in the cell and cell associated matrix, in the same pattern as was observed in the culture medium (Fig. 5B). These results indicate that hypoxia-induced accumulation of PHalpha (I) mRNA leads to elevated protein levels, which then contribute to the maintenance of hydroxylation in ascorbic acid-supplemented cultures as well as to elevation of hydroxylation in ascorbic acid-deficient cultures.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 5.   The hydroxy proline content. Fibroblasts were grown in 10% FCS-DMEM until the culture reached confluent cell density. To analyze hydroxy proline in the culture medium (A), the culture medium was replaced by 0.1% FCS-DMEM, followed by 1 day of culture with or without 200 µM ascorbic acid (ASC) under either 20 or 0% O2. Hydroxy proline content in the culture medium was determined as mentioned under "Experimental Procedures." To analyze the hydroxy proline in the cells and cell-associated matrix (B), subconfluent fibroblasts were cultured for 8 days. The culture medium was changed every other day. After three washes with PBS, the cell layer was harvested by scraping and hydrolyzed, and the level of the 4-hydroxy proline in the hydrolyzate was determined. The data are expressed as nmol of hydroxy proline per µg of DNA, and bars represent 1 S.D. from three independent experiments. Significant differences between the ascorbate-supplemented normoxic culture and ascorbate-deficient or hypoxic cultures are indicated (*, p < 0.05).

Effects of HIF-1 Inducers and Mitochondrial Inhibitors on the PHalpha (I) mRNA Level-- Glucose transporter 1 is up-regulated by depletion of either ATP or oxygen (28). HIF-1 is a transcription factor that regulates hypoxic induction of a variety of genes. CoCl2 and desferroxamine (Des), an iron chelator, can mimic the HIF-1 response to hypoxia (29). To determine whether the HIF-1 related pathway or ATP depletion in mitochondria is involved in the up-regulation of PHalpha (I) by hypoxia, HIF-1 inducers (CoCl2 and Des) and mitochondrial inhibitors (rotenone, azide, and cyanide) were added to the fibroblast cultures. Total RNA was extracted from cells that were treated with chemicals for 16 h and then the PHalpha (I) mRNA level was determined by RNA blotting analysis. CoCl2 (50-200 µM) and Des (50-200 µM) increased the PHalpha (I) mRNA level by 1.8-4.7-fold in a dose-dependent manner (Fig. 6). Rotenone (0.25 and 2.5 µM), NaN3 (1 and 10 µM), and cyanide (3-300 µM) increased the PHalpha (I) mRNA up to 1.3-fold. This increase was far less than that of hypoxic induction.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of CoCl2, desferroxamine, and mitochondrial inhibitors on PHalpha (I) mRNA level. When fibroblast culture reached subconfluence, CoCl2 (50-200 µM), Des (50-200 µM), rotenone (0.25 and 2.5 µM), NaN3 (1 and 10 µM), and KCN (3-300 µM) were added. After 16 h of culture under 20% O2, cells were harvested and analyzed for steady-state PHalpha (I) mRNA level by RNA blotting. The PHalpha mRNA levels were normalized to 28 S rRNA. Levels relative to the control are shown.

Response of the HIF-1-defective Mutant Cell to Hypoxia-- Hepa-c4, the ARNT-defective cell, and Hepa-1, its wild type cell, were exposed to 1, 2, and 20% O2 for 16 h, and analyzed for PHalpha (I) response. The level of PHalpha (I) mRNA in Hepa-1 cells was apparently enhanced (Fig. 7). However, PHalpha (I) mRNA levels in Hepa-c4 cells did not change under hypoxic stress. This result indicates that ARNT may be an essential transcription factor subunit for hypoxic induction of PHalpha (I) mRNA in Hepa-1 cells.


View larger version (61K):
[in this window]
[in a new window]
 
Fig. 7.   Response of ARNT-defective cell to hypoxic stress. The mouse hepatoma cell (Hepa-1) and its ARNT-defective mutant (Hepa-c4) were exposed to hypoxia (2 and 1% O2) for 16 h. Following extraction of total RNA, the steady-state level of PHalpha (I) mRNA was determined by RNA blotting (top). Ethidium bromide staining of total RNA separated in agarose gel by electrophoresis is shown (bottom).

Transcriptional Activity of the PHalpha (I) Promoter-- To assess regulatory elements that delineate hypoxic up-regulation of the PHalpha (I) gene, we screened the rat genomic library against a rat PHalpha (I) cDNA probe containing a 5'-untranslated region. A clone covering from 1.9 kb 5' upstream of the transcription starting site to the first exon2 was selected to analyze responses of the P4Halpha (I) gene to hypoxia (these DNA sequences are not shown, but they have been deposited in the GenBankTM under accession number AF197928). A 1.9-kb fragment (-1.9 kb to +68 bases) of rat PHalpha (I) promotor region was cloned in front of luciferase, and the resulting construct (prPHLUC19, Fig. 8A) was transiently transfected in fibroblasts. Under normoxia, the transfected fibroblasts exhibited 88 times higher luciferase activity than cells transfected by promoterless Luc vector (pGL3-Basic), but 9 times lower activity than the SV40 promoter/enhancer vector (pGL3-Cont.) (Fig. 8B). This suggests that the 1.9-kb promoter region has sufficient promoter activity to invest the hypoxic effects on the gene. Exposure of the transfected fibroblasts to hypoxia for 16 h stimulated luciferase expression by 5.5-fold (Fig. 8B). No significant effect was observed after hypoxic culture of cells transfected with promoter-less or SV40 vectors. Hepa-1 and its ARNT-defective mutant cell, Hepa-c4, were transfected with prPHLUC19. Hepa-1 showed a 3.7-fold induction of luciferase after 16 h of hypoxic culture (Fig. 8B). In contrast, exposure of Hepa-c4 to hypoxia did not affect luciferase expression (Fig. 8B). These results strongly suggest that the PHalpha (I) promoter may contain the hypoxia-responsive consensus sequence, which the HIF-1alpha ·ARNT complex targets. Search for potential binding sites in the promoter region revealed one binding site (-79 to -86) matching the consensus for HIF-1alpha ·ARNT (C/G/T)ACGTGC(G/T) (30) on the antisense strand. A CACAG sequence (31), which seems to be necessary for hypoxic inducibility, was also identified from position -67 to -71 on the antisense strand. To define the promoter region that confers hypoxia responsiveness to PHalpha (I), we determined the luciferase activity of 5'-deletion constructs (Fig. 9A). The prPHLUC(-117), which included the HRE consensus sequence, showed a response to hypoxic exposure: 5.9-fold induction after 16 h of transfection to fetal lung fibroblasts (Fig. 9B). However, the shorter construct, prPHLUC(-68), which lacked the HRE consensus, did not change luciferase activity after hypoxic culture. This HRE involvement in the PHalpha (I) response to hypoxia was further supported by a complete loss of hypoxic induction in a mutated chimera luciferase reporter, prPHLUC(-117)m (Fig. 9B). After 16 h of hypoxia, prPHLUC(-117) showed a 6.0-fold induction in Hepa-1 cells but no change in Hepa-c4 cells (Fig. 9B).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 8.   Stimulation of PHalpha (I) promoter activity by hypoxia. A, structures of reporter gene constructs. A fragment of base pairs -1904 to +68 derived from the PHalpha (I) promoter (prPHLUC19) was cloned in front of the Photinus luciferase gene. B, transient expression assay. Hepa-1 cells, Hepa-c4 cells, and fetal rat lung fibroblasts were transfected by either PHalpha (I)-luciferase chimeric plasmids or the promotor-less luciferase plasmid (pGL3-basic) or the SV40-promoter/enhancer containing luciferase plasmid (pGL3-Control) concomitantly with pRL-SV40, an internal control plasmid containing the Renilla luciferase gene. After 16 h of exposure of the cells to normoxia (20% O2, open bars) or hypoxia (1% O2 for Hepa cells, 0% O2 for the fibroblasts; closed bars), activities of both luciferases in the cell lysate were determined. The activity of Photinus luciferase was normalized to Renilla luciferase and is expressed as relative luciferase activity (mean ± S.D. of at least three independent experiments). Luciferase activities in hypoxic cells relative to those in the normoxic cells are expressed as fold induction, shown at the right.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 9.   Analyses of PHalpha (I) promoter by deletion and mutation. A, structures of reporter gene constructs. The 5'-region of prPHLUC19 was deleted to make prPHLUC(-117) and prPHLUC(-68), which cover base pairs -117 to +68 and base pairs -68 to +68, respectively. The expansion shows a sequence containing the putative HRE. This sequence was mutated in prPHLUC(-117)m. B, transient expression assay. Hepa-1 cells, Hepa-c4 cells, and fetal rat lung fibroblasts were transfected by either PHalpha (I)-luciferase chimeric plasmids, the promotor-less luciferase plasmid (pGL3-basic), or the SV40-promoter/enhancer containing luciferase plasmid (pGL3-Control) concomitantly with pRL-SV40, an internal control plasmid, which contains the Renilla luciferase gene. After 16 h of exposure of the transfected cells to normoxia (20% O2) or hypoxia (1% O2 for Hepa cells, 0% O2 for the fibroblasts), luciferase activity was determined and corrected for transfection efficiency according to the Renilla luciferase activity. Luciferase activities in hypoxic cells relative to those in normoxic cells are indicated. All values represent mean ± S.E. of at least three independent experiments.

DNA Binding Activity to the PHalpha (I) HRE-- To assess whether the HRE consensus sequence identified in the PHalpha (I) promoter was the target of HIF-1, whole cell extracts prepared from Hepa-1 cells were analyzed by electrophoretic mobility shift assays (Fig. 10, lanes 1-7). The PHalpha (I) probe detected hypoxia-specific DNA binding activity (HIF-1) in Hepa-1 cells (Fig. 10, lane 2). This band was absent in normoxic cells (Fig. 10, lane 1). Constitutively expressed DNA binding activity was detected in Hepa-1 cells cultured under both normoxia and hypoxia (Fig. 10, lanes 1 and 2, Con). This hypoxically induced interaction of the PHalpha (I) probe was also observed in whole cell extract prepared from fibroblasts (Fig. 10, lane 14), but no hypoxic induction of DNA binding was identified in whole cell extract from ARNT-defective Hepa-c4 cells (lane 12). The specificity of the interaction between the probe and hypoxia-induced factors was tested by competition with nonradioactive oligonucleotides. An excessive amount of cold PHalpha (I) probe (100× labeled probe) inhibited the binding of the constitutive and inducible complexes (Fig. 10, lane 3). Addition of a mutated PHalpha (I) oligonucleotide (PH-M) did not compete with labeled PHalpha (I) probe. Competition with cold oligonucleotides corresponding to the HRE present in the Epo enhancer (Fig. 10, lane 4, EPO) suggested a binding of the HIF-1alpha ·ARNT complex to PHalpha (I) probe. To further characterize the hypoxia-induced complexes, whole cell extracts were incubated with a monoclonal antibody to HIF-1alpha before the mobility shift assays. Supershift assays showed that HIF-1alpha interacts with the HRE sequence of PHalpha (I) gene (Fig. 10, lane 6). However, Flag monoclonal antibody used as control did not affect the HIF-1 binding to the PHalpha (I) probe (Fig. 10, lane 7).


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 10.   Analysis of HIF-1 DNA binding activity by mobility shift assay. Whole cell extracts prepared from Hepa-1 cells, Hepa-c4 cells, and fetal rat lung fibroblasts, maintained under normoxia (N) or hypoxia (H) for 4 h, were incubated with radioactive PHalpha (I) probe (PH) in the absence or presence (100-fold molar excess) of unlabeled PHalpha (I), erythropoietin (EPO), or mutated PHalpha (I) (PH-M) oligonucleotides. Position of complexes containing constitutive (Con) or HIF-1 binding activity are indicated. Monoclonal antibodies against HIF-1alpha (H1a67) and Flag tag sequence as control antibody were incubated with whole cell extracts, and the DNA, protein, and antibody complex (supershift band) was analyzed. Sequences for probe or competitor and HRE consensus are shown in the bottom panel.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In the late 1970s, Levene and Bates (32), and Turto et al. (33) reported that hypoxia increased enzymatic activity of procollagen prolyl hydroxylase. However, the regulatory step of the enzymatic activity remained unclear. In this report, we have shown that exposure of fetal lung fibroblasts to hypoxia activates the PHalpha (I) gene through the HIF-1 transcription factor complex, the binding of which to the hypoxic responsive element in the 5'-flanking region of the PHalpha (I) gene leads to an increase in transcription rate, steady state level of mRNA, cellular protein level, and hydroxy proline level in the ascorbic acid-deficient culture.

Several pathways have been proposed for gene induction by hypoxic stress (1). The transcription factors HIF-1alpha and HIF-2alpha (34) (also known as HLF or EPAS1) play a major regulatory role in hypoxic gene induction. In addition, nuclear respiratory factor 1 can mediate the hypoxic signal via a decrease in energy production by oxidative-phosphorylation (35). Recently, Disher et al. (36) demonstrated that hypoxia up-regulates beta -enolase gene expression via destabilization of Sp3, a transcription factor. Unknown factors besides HIF-1 have also been suggested (37). The present results show that the mitochondrial inhibitors azide, rotenone, and cyanide do not affect the PHalpha (I) mRNA level (Fig. 6). In contrast, both cobaltous ion and Des up-regulate PHalpha (I) gene expression. CoCl2 and Des mimic HIF-1-mediated hypoxic signals and activate transcription of a variety of genes that are induced by hypoxic stress (29). Moreover, mutant cells incapable of producing ARNT, an essential component of HIF-1 and HIF-2 transcription factor complexes, do not elevate PHalpha (I) mRNA level and reporter gene activities (Figs. 7 and 8). The importance of HIF-1 transcription factor complex and hypoxia-responsive element in the PHalpha (I) gene promoter region were confirmed by the reporter gene assay and the electrophoretic mobility shift assays (Figs. 9 and 10). A promoter region covering from 1.9 kb to the transcription start site, which was ligated to luciferase reporter vector, mimicked the hypoxia-dependent induction. In that PHalpha (I) promoter region, there is one HRE core sequence RCGCT and an adjacent CACAG sequence, which are similar to several known HREs of genes such as Epo and vascular endothelial growth factor (10, 31, 38). These results indicated that the HRE core sequence in PHalpha (I) promoter is functional and primarily responsible for hypoxic enhancement of the transcriptional rate of the PHalpha (I) gene. The binding of the HIF-1 complex to the PHalpha (I) promoter HRE core sequence was further supported by supershift of the PHalpha (I)-HRE probe complex by the addition of a monoclonal antibody against HIF-1alpha and by competition in binding between PHalpha (I) and Epo probes in the electrophoretic mobility shift assays. These data indicate that HIF-1 binding to the HRE core sequence in the PHalpha (I) promoter is important to hypoxic up-regulation of the PHalpha (I) gene.

Hypoxia-mediated PHalpha (I) gene expression could be also modulated at the posttranscriptional level. An increase in the steady state-level of PHalpha (I) mRNA became evident after 8 h of hypoxic exposure (Fig. 2), but the protein level of PHalpha was elevated by 4 h hypoxic exposure (Fig. 4). The fact that the protein response is more rapid than that of the mRNA, may be ascribed to the stabilization of the PHalpha protein under low oxygen conditions. Exposure of C6 glioma cells and PC12 cells to hypoxia increases mRNA levels of vascular endothelial growth factor (39) and tyrosine hydroxylase (40), respectively. Increases in both stability and transcription rate of these mRNAs after hypoxic exposure contribute to their elevated steady state levels. However, the way in which these modifications in the posttranscriptional steps contribute to the hypoxically activated expression of the PHalpha (I) gene remains unclear.

In collagen synthesis, PH is a key enzyme, which catalyzes the formation of 4-hydroxyproline, an essential residue for the folding of the procollagen polypeptide chains into triple helical molecules (41). The active enzyme has two kinds of heterotetramers, each having two pairs of subunits, (alpha (I))2beta 2 and (alpha (II))2beta 2. The alpha  subunits contain the major portion of the catalytic site (42). The beta  subunit is identical to the enzyme protein disulfide-isomerase and is produced in excess of the alpha  subunits (42). Thus, the abundance of the alpha  subunits restricts enzyme activity. For the catalytic reaction of PH activity, Fe2+, 2-oxoglutarate, O2, and ascorbic acid are required. The 2-oxoglutarate is decarboxylated during hydroxylation, with one atom of the O2 molecule being incorporated into the succinate, whereas the other is incorporated into the hydroxyl group formed on the proline residue (41, 42). Although O2 is a requirement for enzymatic activity, the cell culture study done by Levene and Bates (32) showed that exposure of fibroblasts to anoxia (less than 0.1% O2) enhanced hydroxylation of proline in newly synthesized collagen in the cells. The present study has shown that the hydroxy proline content is not affected by hypoxic conditions under ascorbic acid sufficiency (Fig. 5). In the ascorbic acid-deficient culture, hypoxic exposure increased the hydroxy proline content in comparison with the normoxic culture. Reducing reagents such as glutathione and cysteine can be substituted for ascorbic acid to maintain PH catalytic activity in vitro, even though ascorbic acid is the most efficient reducing reagent for PH enzymatic reaction both in vitro and in vivo system (41, 43). In normoxic conditions in the absence of ascorbate, the oxidative environment would convert Fe2+ to Fe3+, which would not support normal hydroxylation. However, under low oxygen, the relative increase in hydroxylation would be due to the increase in prolyl hydroxylase, as well as a preservation of Fe2+. Taken together, these results suggest that in a cell culture system, hypoxic culture may not be the rate-limiting factor in procollagen hydroxylation and may reduce the requirement for ascorbic acid in prolyl hydroxylation.

Hydroxyproline residue is critical in stabilizing triple-helical collagen chains. In addition to collagen, more than 10 proteins, including C1q of complement, acetylcholinesterase, pulmonary surfactant proteins A and D, and conglutinin, have collagen-like domains and are potential substrates for prolyl hydroxylase (41). Secretion of surfactant protein D is inhibited by 2,2'-dipyridyl, an inhibitor of prolyl and lysyl hydroxylase (44). In late pregnancy, pulmonary arterial pO2 in the fetus is less than 3% O2 (45), although synthesis of collagen and surfactant proteins A and D is active in the lung parenchima (46-48). Certainly, this active synthesis is essential for the start of ventilation after the birth. HIF-1 mediated activation of PHalpha (I) may play an important role in maintenance of prolyl hydroxylation of procollagen and collagenous protein under low oxygen conditions in the fetal lung.

    ACKNOWLEDGEMENTS

We thank Dr. O. Hankinson for his generosity in supplying the hepatoma cell lines Hepa-1c1c7 and c4 for the completion of this work, Allen Michael Meyer for excellent proofreading, and Dr. M. Joyce-Brady for useful discussion.

    FOOTNOTES

* This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan (to Y. T. and S. T.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF197928.

Dagger These authors contributed equally to the completion of this study.

§ To whom correspondence should be addressed. Tel.: 81-426-76-7015; Fax: 81-426-76-6811; E-mail: yuji@ls.toyaku.ac.jp.

2 S. Takahashi, Y. Takahashi, and T. Miura, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: HIF, hypoxia-inducible factor; PH, prolyl 4-hydroxylase; HRE, hypoxia-responsive element; ARNT, arylhydrocarbon receptor nuclear translocator; Des, desferroxamine; Hepa-1 cell, Hepa-1c1c7 cell; FCS, fetal calf serum; DMEM, Dulbecco's modified Eagle's medium; TTBS, 0.1% Tween 20-Tris-buffered saline; PBS, phosphate-buffered saline; kb, kilobase(s); CREB, cAMP-response element-binding protein.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Helfman, T., and Falanga, V. (1993) Am. J. Med. Sci. 306, 37-41[Medline] [Order article via Infotrieve]
2. Wang, G. L., Jiang, B.-H., Rue, E. A., and Semenza, G. L. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5510-5514[Abstract/Free Full Text]
3. Huang, L. E., Gu, J., Schau, M., and Bunn, H. F. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 7987-7992[Abstract/Free Full Text]
4. Jiang, B.-H., Rue, E., Wang, G. L., Roe, R., and Semenza, G. L. (1996) J. Biol. Chem. 271, 17771-17778[Abstract/Free Full Text]
5. Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F., and Livingston, D. M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 12969-12973[Abstract/Free Full Text]
6. Firth, J. D., Ebert, B. L., and Ratcliffe, P. J. (1995) J. Biol. Chem. 270, 21021-21027[Abstract/Free Full Text]
7. Li, H., Ko, H. P., and Whitlock, J. P., Jr. (1996) J. Biol. Chem. 271, 21262-21267[Abstract/Free Full Text]
8. Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., and Giallongo, A. (1996) J. Biol. Chem. 271, 32529-32537[Abstract/Free Full Text]
9. Takahashi, Y., Takahashi, S., Yoshimi, T., and Miura, T. (1998) Eur. J. Biochem. 254, 497-504[Medline] [Order article via Infotrieve]
10. Levy, A. P., Levy, N. S., Wegner, S., and Goldberg, M. A. (1995) J. Biol. Chem. 270, 13333-13340[Abstract/Free Full Text]
11. Norris, M. L., and Millhorn, D. E. (1995) J. Biol. Chem. 270, 23774-23779[Abstract/Free Full Text]
12. Durmowicz, A. G., Parks, W. C., Hyde, D. M., Mecham, R. P., and Stenmark, K. R. (1994) Am. J. Pathol. 145, 1411-1420[Abstract]
13. Perhonen, M., Han, X., Wang, W., Karpakka, J., and Takala, T. E. (1996) J. Appl. Physiol. 80, 2226-2233[Abstract/Free Full Text]
14. Ostadal, B., Kolar, F., Pelouch, V., and Widimsky, J. (1995) Physiol. Res. 44, 45-51[Medline] [Order article via Infotrieve]
15. Kim, S. B., Kang, S. A., Park, J. S., Lee, J. S., and Hong, C. D. (1996) Nephron. 72, 275-280[Medline] [Order article via Infotrieve]
16. Falanga, V., Martin, T. A., Takagi, H., Kirsner, R. S., Helfman, T., Pardes, J., and Ochoa, M. S. (1993) J. Cell. Physiol. 157, 408-412[CrossRef][Medline] [Order article via Infotrieve]
17. Hay, E. D. (1991) Collagen , Plenum Press, New York, NY
18. Batenburg, J. J., Otto-Verberne, C. J., Ten-Have-Opbroek, A. A., and Klazinga, W. (1988) Biochim. Biophys. Acta 960, 441-453[Medline] [Order article via Infotrieve]
19. Hoffman, E. C., Reyes, H., Chu, F. F., Sander, F., Conley, L. H., Brooks, B. A., and Hankinson, O. (1991) Science 252, 954-958[Abstract/Free Full Text]
20. Ito, T., Kito, K., Adati, N., Mitsui, Y., Hagiwara, H., and Sakaki, Y. (1994) FEBS Lett. 351, 231-236[CrossRef][Medline] [Order article via Infotrieve]
21. Takahashi, Y., Oakes, S. M., Williams, M. C., Takahashi, S., Miura, T., and Joyce-Brady, M. (1997) Toxicol. Appl. Pharmacol. 143, 388-396[CrossRef][Medline] [Order article via Infotrieve]
22. Takahashi, Y., Takahashi, S., Yoshimi, T., Miura, T., Mochitate, K., and Kobayashi, T. (1997) Biochemical Pharmacol. 53, 1061-1064[CrossRef][Medline] [Order article via Infotrieve]
23. Barbu, V., and Dautry, F. (1989) Nucleic Acids Res. 17, 7115[Free Full Text]
24. Berg, RA. (1982) Methods Enzymol. 82, 372-398
25. Inayama, S., Shibata, T., Ohtsuki, J., and Saito, S. (1978) Keio J. Med. 27, 43-46[Medline] [Order article via Infotrieve]
26. Cesarone, C. F., Bolognesi, C., and Santi, L. (1979) Anal. Biochem. 100, 188-197[CrossRef][Medline] [Order article via Infotrieve]
27. Firth, J. D., Ebert, B. L., Pugh, C. W., and Ratcliffe, P. J. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 6496-6500[Abstract/Free Full Text]
28. Ebert, B. L., Firth, J. D., and Ratcliffe, P. J. (1995) J. Biol. Chem. 270, 29083-29089[Abstract/Free Full Text]
29. Pugh, C. W., O'Rourke, J. F., Nagao, M., Gleadle, J. M., and Ratcliffe, P. J. (1997) J. Biol. Chem. 272, 11205-11214[Abstract/Free Full Text]
30. Semenza, G. L. (1998) J. Lab. Clin. Med. 131, 207-214[CrossRef][Medline] [Order article via Infotrieve]
31. Lok, C. N., and Ponka, P. (1999) J. Biol. Chem. 274, 24147-24152[Abstract/Free Full Text]
32. Levene, C. I., and Bates, C. J. (1976) Biochim. Biophys. Acta 444, 446-452[Medline] [Order article via Infotrieve]
33. Turto, H., Lindy, H., Helin, P., Garbarsch, C., and Lorenzen, I. B. (1979) Atherosclerosis. 33, 379-384[CrossRef][Medline] [Order article via Infotrieve]
34. Ema, M., Hirota, K., Mimura, J., Abe, H., Yodoi, J., Sogawa, K., Poellinger, L., and Fujii-Kuriyama, Y. (1999) EMBO J. 18, 1905-1914[CrossRef][Medline] [Order article via Infotrieve]
35. Virbasius, C. A., Virbasius, J. V., and Scarpulla, R. C. (1993) Genes and Dev. 7, 2431-2445[Abstract/Free Full Text]
36. Discher, D. J., Bishopric, N. H., Wu, X., Peterson, C. A., and Webster, K. A. (1999) J. Biol. Chem. 273, 26087-26093[Abstract/Free Full Text]
37. O'Rourke, J. F., Pugh, C. W., Bartlett, S. M., and Ratcliffe, P. J. (1996) Eur. J. Biochem. 241, 403-410[Medline] [Order article via Infotrieve]
38. Beck, I., Ramirez, S., Weinmann, R., and Caro, J. (1991) J. Biol. Chem. 266, 15563-15566[Abstract/Free Full Text]
39. Ikeda, E., Achen, M. G., Breier, G., and Risau, W. (1995) J. Biol. Chem. 270, 19761-19766[Abstract/Free Full Text]
40. Czyzyk-Krzeska, M. F., and Beresh, J. E. (1996) J. Biol. Chem. 271, 3293-3299[Abstract/Free Full Text]
41. Kivirikko, K. I. (1998) Adv. Enzy. Relat. Areas Mol. Biol. 72, 325-398[Medline] [Order article via Infotrieve]
42. Prockop, D. J., and Kivirikko, K. I. (1995) Annu. Rev. Biochem. 64, 403-434[CrossRef][Medline] [Order article via Infotrieve]
43. Myllyla, R., Kuutti-Savolainen, E. R., and Kivirikko, K. I. (1978) Biochem. Biophys. Res. Commun. 83, 441-448[CrossRef][Medline] [Order article via Infotrieve]
44. Brown-Augsburger, P., Chang, D., Rust, K., and Crouch, E. C. (1996) J. Biol. Chem. 271, 18912-18919[Abstract/Free Full Text]
45. Arbeille, P., Maulik, D., Salihagic, A., Locatelli, A., Lansac, J., and Platt, L. D. (1997) Obstet. Gynecol. 90, 795-802[CrossRef][Medline] [Order article via Infotrieve]
46. Davila, R. M., deMello, D., and Crouch, E. C. (1995) Am. J. Physiol. 268, L309-320[Abstract/Free Full Text]
47. Wasowicz, M., Biczysko, W., Marszalek, A., Yokoyama, S., and Nakayama, I. (1998) Folia. Histochem. Cytobiol. 36, 3-13[Medline] [Order article via Infotrieve]
48. Brody, J. S., and Williams, M. C. (1992) Annu. Rev. Physiol. 54, 351-371[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
Y. Benita, H. Kikuchi, A. D. Smith, M. Q. Zhang, D. C. Chung, and R. J. Xavier
An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia
Nucleic Acids Res., June 2, 2009; (2009) gkp425v1.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. T. S. Brooks, G. P. Elvidge, L. Glenny, J. M. Gleadle, C. Liu, J. Ragoussis, T. G. Smith, N. P. Talbot, L. Winchester, P. H. Maxwell, et al.
Variations within oxygen-regulated gene expression in humans
J Appl Physiol, January 1, 2009; 106(1): 212 - 220.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
A. Wouters, B. Pauwels, F. Lardon, and J. B. Vermorken
Review: Implications of In Vitro Research on the Effect of Radiotherapy and Chemotherapy Under Hypoxic Conditions
Oncologist, June 1, 2007; 12(6): 690 - 712.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Provot, D. Zinyk, Y. Gunes, R. Kathri, Q. Le, H. M. Kronenberg, R. S. Johnson, M. T. Longaker, A. J. Giaccia, and E. Schipani
Hif-1{alpha} regulates differentiation of limb bud mesenchyme and joint development
J. Cell Biol., May 7, 2007; 177(3): 451 - 464.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Q. Ke and M. Costa
Hypoxia-Inducible Factor-1 (HIF-1)
Mol. Pharmacol., November 1, 2006; 70(5): 1469 - 1480.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fahling, R. Mrowka, A. Steege, G. Nebrich, A. Perlewitz, P. B. Persson, and B. J. Thiele
Translational Control of Collagen Prolyl 4-Hydroxylase-{alpha}(I) Gene Expression under Hypoxia
J. Biol. Chem., September 8, 2006; 281(36): 26089 - 26101.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Fandrey, T. A. Gorr, and M. Gassmann
Regulating cellular oxygen sensing by hydroxylation
Cardiovasc Res, September 1, 2006; 71(4): 642 - 651.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Grimmer, N. Balbus, U. Lang, T. Aigner, T. Cramer, L. Muller, B. Swoboda, and D. Pfander
Regulation of Type II Collagen Synthesis during Osteoarthritis by Prolyl-4-Hydroxylases: Possible Influence of Low Oxygen Levels
Am. J. Pathol., August 1, 2006; 169(2): 491 - 502.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Chen, Y. H. Shen, X. Wang, J. Wang, Y. Gan, N. Chen, J. Wang, S. A. LeMaire, J. S. Coselli, and X. L. Wang
Human Prolyl-4-hydroxylase {alpha}(I) Transcription Is Mediated by Upstream Stimulatory Factors
J. Biol. Chem., April 21, 2006; 281(16): 10849 - 10855.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fahling, R. Mrowka, A. Steege, P. Martinka, P. B. Persson, and B. J. Thiele
Heterogeneous Nuclear Ribonucleoprotein-A2/B1 Modulate Collagen Prolyl 4-Hydroxylase, {alpha} (I) mRNA Stability
J. Biol. Chem., April 7, 2006; 281(14): 9279 - 9286.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
R. H. Wenger, D. P. Stiehl, and G. Camenisch
Integration of Oxygen Signaling at the Consensus HRE
Sci. Signal., October 18, 2005; 2005(306): re12 - re12.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Shen, D. Nettleton, M. Jiang, S. K. Kim, and J. A. Powell-Coffman
Roles of the HIF-1 Hypoxia-inducible Factor during Hypoxia Response in Caenorhabditis elegans
J. Biol. Chem., May 27, 2005; 280(21): 20580 - 20588.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. D. Blais, V. Filipenko, M. Bi, H. P. Harding, D. Ron, C. Koumenis, B. G. Wouters, and J. C. Bell
Activating Transcription Factor 4 Is Translationally Regulated by Hypoxic Stress
Mol. Cell. Biol., September 1, 2004; 24(17): 7469 - 7482.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
I. Fajardo, L. Svensson, A. Bucht, and G. Pejler
Increased Levels of Hypoxia-sensitive Proteins in Allergic Airway Inflammation
Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 477 - 484.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Wellmann, C. Buhrer, E. Moderegger, A. Zelmer, R. Kirschner, P. Koehne, J. Fujita, and K. Seeger
Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism
J. Cell Sci., May 1, 2004; 117(9): 1785 - 1794.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Schmidt, F. Gerlach, A. Avivi, T. Laufs, S. Wystub, J. C. Simpson, E. Nevo, S. Saaler-Reinhardt, S. Reuss, T. Hankeln, et al.
Cytoglobin Is a Respiratory Protein in Connective Tissue and Neurons, Which Is Up-regulated by Hypoxia
J. Biol. Chem., February 27, 2004; 279(9): 8063 - 8069.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. O. Leonard, D. C. Cottell, C. Godson, H. R. Brady, and C. T. Taylor
The Role of HIF-1{alpha} in Transcriptional Regulation of the Proximal Tubular Epithelial Cell Response to Hypoxia
J. Biol. Chem., October 10, 2003; 278(41): 40296 - 40304.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Salnikow, T. Davidson, Q. Zhang, L. C. Chen, W. Su, and M. Costa
The Involvement of Hypoxia-inducible Transcription Factor-1-dependent Pathway in Nickel Carcinogenesis
Cancer Res., July 1, 2003; 63(13): 3524 - 3530.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
D. O. Bates and R. O. P. Jones
The Role of Vascular Endothelial Growth Factor in Wound Healing
International Journal of Lower Extremity Wounds, June 1, 2003; 2(2): 107 - 120.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Ivan, T. Haberberger, D. C. Gervasi, K. S. Michelson, V. Gunzler, K. Kondo, H. Yang, I. Sorokina, R. C. Conaway, J. W. Conaway, et al.
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
PNAS, October 15, 2002; 99(21): 13459 - 13464.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bernaudin, Y. Tang, M. Reilly, E. Petit, and F. R. Sharp
Brain Genomic Response following Hypoxia and Re-oxygenation in the Neonatal Rat. IDENTIFICATION OF GENES THAT MIGHT CONTRIBUTE TO HYPOXIA-INDUCED ISCHEMIC TOLERANCE
J. Biol. Chem., October 11, 2002; 277(42): 39728 - 39738.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. H. WENGER
Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression
FASEB J, August 1, 2002; 16(10): 1151 - 1162.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Masamune, K. Kikuta, M. Satoh, Y. Sakai, A. Satoh, and T. Shimosegawa
Ligands of Peroxisome Proliferator-activated Receptor-gamma Block Activation of Pancreatic Stellate Cells
J. Biol. Chem., January 4, 2002; 277(1): 141 - 147.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Yu, S. B. White, Q. Zhao, and F. S. Lee
HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation
PNAS, August 14, 2001; 98(17): 9630 - 9635.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. C. Clifford, M. E. Cockman, A. C. Smallwood, D. R. Mole, E. R. Woodward, P. H. Maxwell, P. J. Ratcliffe, and E. R. Maher
Contrasting effects on HIF-1{{alpha}} regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease
Hum. Mol. Genet., May 1, 2001; 10(10): 1029 - 1038.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. Ivan, K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J. M. Asara, W. S. Lane, and W. G. Kaelin Jr.
HIFalpha Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing
Science, April 20, 2001; 292(5516): 464 - 468.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. K. Graven, C. Molvar, J. S. Roncarati, B. D. Klahn, S. Lowrey, and H. W. Farber
Identification of protein disulfide isomerase as an endothelial hypoxic stress protein
Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L996 - L1003.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Miura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Miura, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement